Literature DB >> 23455316

[Biocompatibility of polymer-bioglass cement Cortoss®: in vitro test with the MG63 cell model].

C Fölsch1, R Pinkernell, R Stiletto.   

Abstract

BACKGROUND: Polymethylmethacrylate (PMMA) cement has been used for fixation of joint replacements for more than 50 years and cement augmentation of vertebrae has become a popular procedure since the first description in 1987. New cements have now been developed which are better suited to the requirements of minimally invasive application techniques for vertebral bodies. The combination of good mechanical properties and biocompatibility is the concern of present research. This study compared the features of a polymer-bioglass cement with a calcium phosphate cement used for vertebral augmentation.
METHODS: The human osteoblast-like cell culture MG63 was used to study the polymer-glass ceramic cement Cortoss® and the hydroxyapatite cement Kyphos®. Every 24 h for 5-6 days a defined volume of the culture medium was harvested in the presence of the bone cements and added to 16 cell cultures for each time period. The viability of cells was determined photometrically at 550 nm with the MTT assay and cell morphology was studied using light and electron microscopy.
RESULTS: In the presence of the calcium phosphate cement an early and small reduction of cell activity was found compared with the controls. At the end of 1 week the viability parameter improved nearly reaching the control level. Electron microscopy showed crystals with a 3-dimensional shape. The cell cultures with Cortoss® showed no cellular activity and the microscopic examinations were negative. This effect was not different at days 1-5 after polymerization of the cement.
CONCLUSIONS: The calcium phosphate cement studied showed a good biocompatibility and allowed morphological signs of apatite formation. At least within the first 5 days the polymer-glass ceramic cement showed a reasonable cytotoxic effect. There was no sign of recovery of cell function within that period. The biocompatibility of the polymer-glass ceramic cement appeared significantly worse compared with the calcium phosphate cement. An ideal composition of biomechanical properties and biocompatibility has not been achieved so far.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23455316     DOI: 10.1007/s00132-013-2062-8

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  40 in total

1.  Biocompatibility of alendronate-loaded acrylic cement for vertebroplasty.

Authors:  T Calvo-Fernández; J Parra; M Fernández-Gutiérrez; B Vázquez-Lasa; A López-Bravo; F Collía; M A Pérez de la Cruz; J San Román
Journal:  Eur Cell Mater       Date:  2010-10-05       Impact factor: 3.942

2.  Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption.

Authors:  A Sabokbar; Y Fujikawa; D W Murray; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

3.  Vertebroplasty by use of a strontium-containing bioactive bone cement.

Authors:  Kenneth M C Cheung; William W Lu; Keith D K Luk; C T Wong; Danny Chan; J X Shen; G X Qiu; Z M Zheng; C H Li; S L Liu; W K Chan; John C Y Leong
Journal:  Spine (Phila Pa 1976)       Date:  2005-09-01       Impact factor: 3.468

4.  Response of human osteoblasts to polymethylmetacrylate In vitro.

Authors:  G Zambonin; S Colucci; F Cantatore; M Grano
Journal:  Calcif Tissue Int       Date:  1998-04       Impact factor: 4.333

5.  Biomechanical, histological and histomorphometric analyses of calcium phosphate cement compared to PMMA for vertebral augmentation in a validated animal model.

Authors:  Luis Alvarez Galovich; Antonio Perez-Higueras; Jose R Altonaga; José Manuel Gonzalo Orden; Maria Lluisa Mariñoso Barba; Maria Teresa Carrascal Morillo
Journal:  Eur Spine J       Date:  2011-07-20       Impact factor: 3.134

6.  Thermal aspects of the use of polymethylmethacrylate in large metaphyseal defects in bone. A clinical review and laboratory study.

Authors:  M C Leeson; S B Lippitt
Journal:  Clin Orthop Relat Res       Date:  1993-10       Impact factor: 4.176

7.  In vitro adhesion and biocompatability of osteoblast-like cells to poly(methylmethacrylate) and poly(ethylmethacrylate) bone cements.

Authors:  M J Dalby; L Di Silvio; E J Harper; W Bonfield
Journal:  J Mater Sci Mater Med       Date:  2002-03       Impact factor: 3.896

8.  Comparison of an experimental bone cement with surgical Simplex P, Spineplex and Cortoss.

Authors:  D Boyd; M R Towler; A Wren; O M Clarkin
Journal:  J Mater Sci Mater Med       Date:  2008-01-16       Impact factor: 3.896

9.  Methotrexate-added acrylic cement: biological and physical properties.

Authors:  G Maccauro; A Cittadini; M Casarci; F Muratori; D De Angelis; C Piconi; M A Rosa; A Spadoni; M Braden; A Sgambato
Journal:  J Mater Sci Mater Med       Date:  2007-01-04       Impact factor: 4.727

10.  Morphological changes of injected calcium phosphate cement in osteoporotic compressed vertebral bodies.

Authors:  H D Heo; Y J Cho; S H Sheen; S U Kuh; S M Cho; S M Oh
Journal:  Osteoporos Int       Date:  2009-12       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.